login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Blood Thinner Drug Could Be Used to Treat Lung Cancer
December 24, 2007 at 1:27 PM
Cancer News
Doctors at Velindre Hospital, in Cardiff, UK, are leading the Fragmatic trial – one of the world’s largest lung cancer clinical trials – which will investigate how the drug might help prevent potentially deadly blood clots in lung cancer patients.
The Cancer Research UK-funded trial will determine whether Dalteparin (or Fragmin) can treat this problem and whether the drug may also improve the survival of lung cancer patients.
People with lung cancer are at an increased risk of blood clots in their veins because of chemotherapy, surgery, inactivity or the lung cancer itself. Clots can be dangerous and even fatal if they dislodge and travel to the lungs. They can also cause pain in the chest and breathlessness.
But fragmin may also have an anti-cancer effect and lead to an improvement in quality of life and survival rates after the lung cancer diagnosis. It is thought that the blood thinning drug may affect how cancer cells spread through the blood stream, but this is not known for sure.
The trial has been designed to help answer these questions and to identify any possible side-effects of using the drug in this situation.
The trial, which was created by Dr Fergus Macbeth and Dr Simon Noble at Velindre Hospital, is hoping to recruit 2,400 patients and is due to involve between 50 and 100 centres around the UK.
Dr Macbeth, the lead researcher on the trial, said, “Blood clots are quite common in people who have lung cancer and may be dangerous. With this research, we hope to learn how to reduce the risk of this problem and improve the treatment for patients. We are working hard to find better and more effective ways to treat this difficult
|
|
|
More News on: Drug Toxicity, Blood Group, Lung Cancer, Malignant Mesothelioma, Cancer and Homeopathy, Blood Group Calculator, Signature Drug Toxicity, Cancer Facts, Asbestosis , Cancer
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | Report: A Lot of Americans Have No Access to Health Care |
| » | Greece Faces Humanitarian Crisis as Health Care Access Declines in EU, Doctors Group Warns |
| » | HCCI Report Says Rising Prices for Care Responsible for Increased Healthcare Costs for Privately Insured Americans |
| » | Treatment in ED is Based on Children's Insurance Status |
| » | US Spends Most on Healthcare Without Providing Superior Care |
| More Insurance News | |
|
Cancer Related News |
||||||||
| » | Scientists Develop Compound That Triggers Cancer Cell Death | » | Iraqi National Hopes to Find Affordable Treatment for His Cancer in India | |||||
| » | New Technique can Help Doctors Detect Pancreatic Cancer | » | Colorectal Cancer Risk Factors Probed | |||||
| » | Breast MRI 'Better Than Clinical Approach for Predicting Chemotherapy's Efficiency' | » | No Need for PSA-Based Screening for Prostate Cancer: Task Force | |||||
| » | Blocking Protein Reduces Risk of Heart Damage After Chemo | » | Researchers Identify Early-life Risk Factors for Non-Hodgkin Lymphoma | |||||
| Read More >> | ||||||||
